Copyright Reports & Markets. All rights reserved.

Global Pentavalent Vaccine Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Pentavalent Vaccine Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Lyophilized
    • 1.3.3 Liquid
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Pentavalent Vaccine Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Retail Pharmacy
    • 1.4.3 Hospital Pharmacy
    • 1.4.4 E-commerce
  • 1.5 Global Pentavalent Vaccine Market Size & Forecast
    • 1.5.1 Global Pentavalent Vaccine Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Pentavalent Vaccine Sales Quantity (2021-2032)
    • 1.5.3 Global Pentavalent Vaccine Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Serum Institute of India
    • 2.1.1 Serum Institute of India Details
    • 2.1.2 Serum Institute of India Major Business
    • 2.1.3 Serum Institute of India Pentavalent Vaccine Product and Services
    • 2.1.4 Serum Institute of India Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Serum Institute of India Recent Developments/Updates
  • 2.2 Panacea Drugs Pvt. Ltd
    • 2.2.1 Panacea Drugs Pvt. Ltd Details
    • 2.2.2 Panacea Drugs Pvt. Ltd Major Business
    • 2.2.3 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Product and Services
    • 2.2.4 Panacea Drugs Pvt. Ltd Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Panacea Drugs Pvt. Ltd Recent Developments/Updates
  • 2.3 Shantha Biotechnics
    • 2.3.1 Shantha Biotechnics Details
    • 2.3.2 Shantha Biotechnics Major Business
    • 2.3.3 Shantha Biotechnics Pentavalent Vaccine Product and Services
    • 2.3.4 Shantha Biotechnics Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Shantha Biotechnics Recent Developments/Updates
  • 2.4 Biological E. Ltd.
    • 2.4.1 Biological E. Ltd. Details
    • 2.4.2 Biological E. Ltd. Major Business
    • 2.4.3 Biological E. Ltd. Pentavalent Vaccine Product and Services
    • 2.4.4 Biological E. Ltd. Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Biological E. Ltd. Recent Developments/Updates
  • 2.5 Novartis AG
    • 2.5.1 Novartis AG Details
    • 2.5.2 Novartis AG Major Business
    • 2.5.3 Novartis AG Pentavalent Vaccine Product and Services
    • 2.5.4 Novartis AG Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Novartis AG Recent Developments/Updates
  • 2.6 Crucell
    • 2.6.1 Crucell Details
    • 2.6.2 Crucell Major Business
    • 2.6.3 Crucell Pentavalent Vaccine Product and Services
    • 2.6.4 Crucell Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Crucell Recent Developments/Updates
  • 2.7 Bio Farma
    • 2.7.1 Bio Farma Details
    • 2.7.2 Bio Farma Major Business
    • 2.7.3 Bio Farma Pentavalent Vaccine Product and Services
    • 2.7.4 Bio Farma Pentavalent Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bio Farma Recent Developments/Updates

3 Competitive Environment: Pentavalent Vaccine by Manufacturer

  • 3.1 Global Pentavalent Vaccine Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Pentavalent Vaccine Revenue by Manufacturer (2021-2026)
  • 3.3 Global Pentavalent Vaccine Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Pentavalent Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Pentavalent Vaccine Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Pentavalent Vaccine Manufacturer Market Share in 2025
  • 3.5 Pentavalent Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Pentavalent Vaccine Market: Region Footprint
    • 3.5.2 Pentavalent Vaccine Market: Company Product Type Footprint
    • 3.5.3 Pentavalent Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Pentavalent Vaccine Market Size by Region
    • 4.1.1 Global Pentavalent Vaccine Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Pentavalent Vaccine Consumption Value by Region (2021-2032)
    • 4.1.3 Global Pentavalent Vaccine Average Price by Region (2021-2032)
  • 4.2 North America Pentavalent Vaccine Consumption Value (2021-2032)
  • 4.3 Europe Pentavalent Vaccine Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Pentavalent Vaccine Consumption Value (2021-2032)
  • 4.5 South America Pentavalent Vaccine Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Pentavalent Vaccine Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Pentavalent Vaccine Sales Quantity by Type (2021-2032)
  • 5.2 Global Pentavalent Vaccine Consumption Value by Type (2021-2032)
  • 5.3 Global Pentavalent Vaccine Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Pentavalent Vaccine Sales Quantity by Application (2021-2032)
  • 6.2 Global Pentavalent Vaccine Consumption Value by Application (2021-2032)
  • 6.3 Global Pentavalent Vaccine Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Pentavalent Vaccine Sales Quantity by Type (2021-2032)
  • 7.2 North America Pentavalent Vaccine Sales Quantity by Application (2021-2032)
  • 7.3 North America Pentavalent Vaccine Market Size by Country
    • 7.3.1 North America Pentavalent Vaccine Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Pentavalent Vaccine Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Pentavalent Vaccine Sales Quantity by Type (2021-2032)
  • 8.2 Europe Pentavalent Vaccine Sales Quantity by Application (2021-2032)
  • 8.3 Europe Pentavalent Vaccine Market Size by Country
    • 8.3.1 Europe Pentavalent Vaccine Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Pentavalent Vaccine Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Pentavalent Vaccine Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Pentavalent Vaccine Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Pentavalent Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Pentavalent Vaccine Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Pentavalent Vaccine Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Pentavalent Vaccine Sales Quantity by Type (2021-2032)
  • 10.2 South America Pentavalent Vaccine Sales Quantity by Application (2021-2032)
  • 10.3 South America Pentavalent Vaccine Market Size by Country
    • 10.3.1 South America Pentavalent Vaccine Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Pentavalent Vaccine Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Pentavalent Vaccine Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Pentavalent Vaccine Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Pentavalent Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Pentavalent Vaccine Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Pentavalent Vaccine Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Pentavalent Vaccine Market Drivers
  • 12.2 Pentavalent Vaccine Market Restraints
  • 12.3 Pentavalent Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Pentavalent Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Pentavalent Vaccine
  • 13.3 Pentavalent Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Pentavalent Vaccine Typical Distributors
  • 14.3 Pentavalent Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Pentavalent Vaccine market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    A pentavalent vaccine is a five-in-one vaccine that protects against diphtheria, tetanus, and whooping cough, hepatitis B, and Haemophilus influenza type b with just one dosage. One of the most well-known and successful techniques of preventing paediatric diseases is vaccination. The Government of India has achieved tremendous progress in preventing and controlling vaccine-preventable diseases since implementing the Universal Immunization Programme (UIP) (VPDs). The introduction of a pentavalent vaccination will help to minimise the number of cases of pneumonia and meningitis caused by the germs Haemophilus influenzae type b (Hib).
    This report is a detailed and comprehensive analysis for global Pentavalent Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Pentavalent Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Pentavalent Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Pentavalent Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Pentavalent Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Pentavalent Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Pentavalent Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Serum Institute of India, Panacea Drugs Pvt. Ltd, Shantha Biotechnics, Biological E. Ltd., Novartis AG, Crucell, Bio Farma, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Pentavalent Vaccine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Lyophilized
    Liquid
    Market segment by Application
    Retail Pharmacy
    Hospital Pharmacy
    E-commerce
    Major players covered
    Serum Institute of India
    Panacea Drugs Pvt. Ltd
    Shantha Biotechnics
    Biological E. Ltd.
    Novartis AG
    Crucell
    Bio Farma
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Pentavalent Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Pentavalent Vaccine, with price, sales quantity, revenue, and global market share of Pentavalent Vaccine from 2021 to 2026.
    Chapter 3, the Pentavalent Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Pentavalent Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Pentavalent Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Pentavalent Vaccine.
    Chapter 14 and 15, to describe Pentavalent Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now